There are 101 resources available
Welcome and introduction
Presenter: Ana Oaknin
Session: GSK - Using biomarkers to guide targeted therapy in gynaecological cancers
Resources:
Webcast
Can biomarkers guide targeted treatment for recurrent endometrial cancer?
Presenter: Giorgio Valabrega
Session: GSK - Using biomarkers to guide targeted therapy in gynaecological cancers
Resources:
Webcast
How and when should HRD testing guide treatment for 1L advanced ovarian cancer?
Presenter: Christoph Grimm
Session: GSK - Using biomarkers to guide targeted therapy in gynaecological cancers
Resources:
Webcast
Q&A from audience
Presenter: The Panelists
Session: GSK - Using biomarkers to guide targeted therapy in gynaecological cancers
Resources:
Webcast
Final discussion and closing remarks
Presenter: Ana Oaknin
Session: GSK - Using biomarkers to guide targeted therapy in gynaecological cancers
Resources:
Webcast
1P - Comprehensive assessment of gene mutations revealed overlapping responses for PARPi and chemotherapy in ovarian cancer cells
Presenter: Alessandra Tozzi
Session: Poster Display session
2P - Spectrum of BRCA1, BRCA1, ATM and PALB2 alleles in ovarian cancer patients from North Caucasus
Presenter: Evgeny Imyanitov
Session: Poster Display session
3P - Identification of novel biomarkers of response to ATR inhibitors in ARID1A mutant ovarian clear cell carcinoma.
Presenter: James Stewart
Session: Poster Display session
4P - Targeting PI3K/AKT/mTOR pathway in platinum-resistant ovarian high-grade serous carcinoma: Translational analysis from the randomized phase II OCTOPUS Trial.
Presenter: gaia Giannone
Session: Poster Display session
5P - HOX Gene Dysregulation in Endometrioid Ovarian Cancer
Presenter: Praveena Idaikkadar
Session: Poster Display session